Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
The Hippo pathway is an evolutionarily conserved signalling pathway with key roles in
organ development, epithelial homeostasis, tissue regeneration, wound healing and …
organ development, epithelial homeostasis, tissue regeneration, wound healing and …
Hippo signalling in the liver: role in development, regeneration and disease
JO Russell, FD Camargo - Nature reviews Gastroenterology & …, 2022 - nature.com
The Hippo signalling pathway has emerged as a major player in many aspects of liver
biology, such as development, cell fate determination, homeostatic function and …
biology, such as development, cell fate determination, homeostatic function and …
[HTML][HTML] Emerging role of tumor cell plasticity in modifying therapeutic response
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …
have proposed that acquisition of resistance may result from genetic mutations. However …
YAP and TAZ: a signalling hub of the tumour microenvironment
F Zanconato, M Cordenonsi, S Piccolo - Nature Reviews Cancer, 2019 - nature.com
YAP and TAZ are transcriptional activators pervasively induced in several human solid
tumours and their functions in cancer cells are the focus of intense investigation. These …
tumours and their functions in cancer cells are the focus of intense investigation. These …
Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment
Liver metastasis is a major cause of death in patients with colorectal cancer (CRC). Fatty
liver promotes liver metastasis, but the underlying mechanism remains unclear. We …
liver promotes liver metastasis, but the underlying mechanism remains unclear. We …
YAP/TAZ signaling and resistance to cancer therapy
CDK Nguyen, C Yi - Trends in cancer, 2019 - cell.com
Drug resistance is a major challenge in cancer treatment. Emerging evidence indicates that
deregulation of YAP/TAZ signaling may be a major mechanism of intrinsic and acquired …
deregulation of YAP/TAZ signaling may be a major mechanism of intrinsic and acquired …
[HTML][HTML] Immunotherapy in treating EGFR-mutant lung cancer: current challenges and new strategies
KKW To, W Fong, WCS Cho - Frontiers in Oncology, 2021 - frontiersin.org
Lung cancer is the leading cause of cancer-related deaths worldwide. Immune checkpoint
inhibitors, including monoclonal antibodies against programmed death-1 (PD-1) and …
inhibitors, including monoclonal antibodies against programmed death-1 (PD-1) and …
[HTML][HTML] The intracellular signalosome of PD-L1 in cancer cells
Abstract Programmed cell death-1 ligand-1 (PD-L1) overexpression in cancer cells
accelerates tumor progression. PD-L1 possesses two main pro-oncogenic functions. First …
accelerates tumor progression. PD-L1 possesses two main pro-oncogenic functions. First …
[HTML][HTML] Regulation of TEAD transcription factors in cancer biology
HD Huh, DH Kim, HS Jeong, HW Park - Cells, 2019 - mdpi.com
Transcriptional enhanced associate domain (TEAD) transcription factors play important roles
during development, cell proliferation, regeneration, and tissue homeostasis. TEAD …
during development, cell proliferation, regeneration, and tissue homeostasis. TEAD …
[HTML][HTML] Epidermal growth factor receptor (EGFR) pathway, yes-associated protein (YAP) and the regulation of programmed death-ligand 1 (PD-L1) in non-small cell …
PC Hsu, DM Jablons, CT Yang, L You - International journal of molecular …, 2019 - mdpi.com
The epidermal growth factor receptor (EGFR) pathway is a well-studied oncogenic pathway
in human non-small cell lung cancer (NSCLC). A subset of advanced NSCLC patients (15 …
in human non-small cell lung cancer (NSCLC). A subset of advanced NSCLC patients (15 …